Jacob Byerley-Duke

Jacob Byerley-Duke

Auto-generated profile, based on publicly available information

Jacob Byerley-Duke

Department of Chemistry Iowa State University Ames IA 50011 USA

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 December 2022 in Journal of the American Chemical Society
Verified
Journal Article
Closed access
EOEmily A. O’bRien
Emily A. O’bRien
KSKrishna K. Sharma
Krishna K. Sharma
JBJacob Byerly-Duke
Jacob Byerly-Duke
LCLuis A. Camacho
Luis A. Camacho
BVBrett VanVeller
Brett VanVeller

9 June 2026 in The Journal of Organic Chemistry
Verified
Journal Article
Closed access
AIAmber Iqbal
Amber Iqbal
JBJacob Byerly-Duke
Jacob Byerly-Duke
RGReece S. Gardner
Reece S. Gardner
BVBrett VanVeller
Brett VanVeller

14 July 2025 in Angewandte Chemie
Verified
Journal Article
Open access
SKSelin Kinali-Demirci
Selin Kinali-Demirci
SDSerkan Demirci
Serkan Demirci
JBJacob Byerly‐Duke
Jacob Byerly‐Duke
BVBrett VanVeller
Brett VanVeller
The first reactions of thioimidates under radical‐mediated conditions are described along with the delineation of structural factors that impact radical reactivity and possible side reactions. Thioimidate‐containing copolymers with methylmethacrylate (MMA) are synthesized through radical‐mediated, chain‐growth polymerization. These materials serve as a synthetic branch point for facile conversion into amidines by treatment with a weak acid and an external amine. Our approach allows for more diverse amidine structures than have been previously reported in polymers. This chemistry also enables crosslinking to form novel hydrogels with finely tuned acid–base behavior. Subsequent examination of the acid–base properties revealed that these features are preserved across linear, soluble amidine polymers to cross‐linked amidine gel polymer architectures.

14 July 2025 in Angewandte Chemie International Edition
Verified
Journal Article
Open access
SKSelin Kinali-Demirci
Selin Kinali-Demirci
SDSerkan Demirci
Serkan Demirci
JBJacob Byerly‐Duke
Jacob Byerly‐Duke
BVBrett VanVeller
Brett VanVeller
The first reactions of thioimidates under radical‐mediated conditions are described along with the delineation of structural factors that impact radical reactivity and possible side reactions. Thioimidate‐containing copolymers with methylmethacrylate (MMA) are synthesized through radical‐mediated, chain‐growth polymerization. These materials serve as a synthetic branch point for facile conversion into amidines by treatment with a weak acid and an external amine. Our approach allows for more diverse amidine structures than have been previously reported in polymers. This chemistry also enables crosslinking to form novel hydrogels with finely tuned acid–base behavior. Subsequent examination of the acid–base properties revealed that these features are preserved across linear, soluble amidine polymers to cross‐linked amidine gel polymer architectures.

8 September 2026 in PLOS Neglected Tropical Diseases
Verified
Journal Article
Open access
PDF file
PWPaul D. E. Williams
Paul D. E. Williams
DBDavid J. Borts
David J. Borts
DLDongjie Liu
Dongjie Liu
JBJacob Byerley-Duke
Jacob Byerley-Duke
BVBrett VanVeller
Brett VanVeller
RMRichard Martin
Richard Martin
Anthelmintic drugs are used to control soil-transmitted helminths that infect a quarter of the world’s human population. There is increasing concern about the development of resistance to anthelmintic drugs because of the limited number of compounds available and there is an unmet need for new resistance-busting drugs. Here we describe the presence of a previously unrecognized endogenous acetylcholine (ACh) analogue, β-alanine betaine, which may serve as an endogenous ligand for an alternate subfamily of nicotinic receptors (DEG-3/DES-2) that could be developed as novel drug targets because their analogues are not present in their human or animal hosts. We collected pseudocoelomic fluid from female Ascaris suum (a model for the human parasite Ascaris lumbricoides ) and subjected it to HILIC-MS and HILIC-MS/MS to reveal signals consistent with ACh, choline, and β - alanine betaine but not betaine, propionylcholine, butyrylcholine, or butyrobetaine. The presence of β-alanine betaine was confirmed by comparison with an analytical standard. Injection of betaine into female A. suum produced no effect. However, injection of β - alanine betaine produced characteristic pretzel coiling and injection of levamisole produced a rod-like spastic paralysis. The differences between β - alanine betaine and levamisole suggested that they activate different nAChRs subfamilies. RT-PCR showed that message for members of the DEG-3/DES-2 subfamily of nAChR channels, which are betaine targets, were present in the intestine and body wall of A. suum . β - alanine betaine increased intracellular Ca 2+ of the intestinal enterocytes and depolarized the membrane potential of body wall muscle cells. In N2 Caenorhabditis elegans, application of β - alanine betaine produced gradual inhibition of motility, which was reduced in acr-20, acr-23, deg-3/des-2 and lgc-41 null-mutants. These observations suggest that, in addition to ACh, β-alanine betaine - an analog of betaine produced under anaerobic conditions - may function as an endogenous ligand in anaerobic nematodes such as A. suum . An expanded repertoire of nicotinic acetylcholine receptor subfamilies in nematodes relative to mammals may reflect a corresponding need for diversification of cholinergic endogenous ligands in these organisms. This repertoire could allow their simpler neuronal system to perform more complex controls and be exploited for development of different and novel subfamily selective cholinergic anthelmintics.

3 July 2026 in bioRxiv
Verified
Preprint
Open access
PWPaul D. E. Williams
Paul D. E. Williams
DBDavid J. Borts
David J. Borts
DLDongjie Liu
Dongjie Liu
JBJacob Byerley-Duke
Jacob Byerley-Duke
BVBrett VanVeller
Brett VanVeller
RMRichard Martin
Richard Martin
Anthelmintic drugs are used to control soil-transmitted helminths that infect a third of the world’s human population. There is increasing concern about the development of resistance to anthelmintic drugs because of the limited number of compounds available and there is an unmet need for new resistance-busting drugs. Here we describe the presence of a previously unrecognized endogenous acetylcholine analogue, β-alanine betaine, which may serve as an endogenous ligand for an alternate subfamily of nicotinic receptors (DEG-3/DES-2) that could be developed as novel drug targets because their analogues are not present in their human or animal hosts. We collected peri-enteric fluid from female Ascaris suum (a model for the human parasite, Ascaris lumbricoides ) and subjected it to chromatography and MS/MS to reveal signals consistent with acetylcholine, choline, and β - alanine betaine but we did not recover betaine. We injected betaine into female Ascaris suum which produced no effect. However, injection of β - alanine betaine, produced characteristic pretzel coiling and injection of levamisole produced a rod-like spastic paralysis. The differences between β - alanine betaine and levamisole suggested that they activate different nAChRs subfamilies. PCR showed that messages of the DEG-3 subfamily of nAChR channels, which are betaine targets and were present in the intestine and body wall of A. suum . Calcium signaling experiments showed that β - alanine betaine increased intracellular calcium of the intestine enterocytes and electrophysiology of the body muscle cells demonstrated that β - alanine betaine produced membrane potential depolarization. In N2 elegans, application of β - alanine betaine produced gradual inhibition of motility, which was reduced in acr-20, acr-23, des-2, deg-3 and lgc-41 null-mutants. These observations suggest that, in addition to acetylcholine, β-alanine betaine - an anaerobic analog of betaine - may function as an endogenous ligand in anaerobic nematodes such as A. suum . An expanded repertoire of nicotinic acetylcholine receptor subfamilies in nematodes relative to mammals may reflect a corresponding need for diversification of cholinergic endogenous ligands in these organisms. This repertoire could allow their simpler neuronal system to perform more complex controls and be exploited for development of different and novel subfamily selective cholinergic anthelmintics. Author Summary: There is increasing concern about the development of resistance to anthelmintic drugs because of the limited number of compounds available and there is an unmet need for new resistance-busting drugs. The cholinergic anthelmintics are one of the three major classes of anti-nematodal drugs that are used for control and treatment of soil-transmitted helminths. Each of these cholinergic anthelmintics (levamisole, pyrantel, derquantel, monepantel and oxantel) are selective for different nematode nicotinic acetylcholine receptors (nAChRs). The differences in selectivity could explain why resistance and species sensitivities varies across the different cholinergic anthelmintics. It is surprising how many nAChR genes are expressed in nematodes with more being present compared to humans. Why is this? Could it be that there are also more endogenous ligands other than acetylcholine allowing their simpler neuronal system to perform more complex control? We looked for additional analogues of acetylcholine in the body fluid of the large intestinal parasite of the pig Ascaris suum (a model for Ascaris lumbricoides ) and identified the anaerobic cholinergic compound β-alanine betaine. We found evidence that suggests that β-alanine betaine may serve as an endogenous ligand for an alternate subfamily of nicotinic receptors (DEG-3/DES-2) that could be developed as novel drug targets because their receptor analogues are not present in human or animal hosts.